Publication | Closed Access
Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis
85
Citations
21
References
2010
Year
InflammationMolecular PharmacologyHematological MalignancyMedicineImmunologyHematologyPhase Ii StudyPharmacotherapyObatoclax MesylatePharmacologyMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1